A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Wakelee, Heather A., Gettinger, Scott, Engelman, Jeffrey, Jänne, Pasi A., West, Howard, Subramaniam, Deepa S., Leach, Joseph, Wax, Michael, Yaron, Yifah, Miles, Dale R., Lara, Primo N.Volume:
79
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-017-3283-z
Date:
May, 2017
File:
PDF, 684 KB
english, 2017